Austco Healthcare Reports Robust Revenue and EBITDA Growth

The latest announcement is out from Austco Healthcare Limited ( (AU:AHC) ).

Austco Healthcare Limited reported a significant increase in its financial performance for the six months ending December 2024, with revenues rising by 62% to $36.9 million and EBITDA soaring by 150% to $5.2 million. This growth was driven by the successful integration of recently acquired businesses, Teknocorp and Amentco, which contributed $11.9 million to the revenue, and strong organic growth in Asia and North America. Despite a slight reduction in gross margins due to the lower margins of the acquired businesses, the company maintained a steady gross margin dollar amount. The increase in software and SMA revenues by 15% to $4.6 million highlights the strategic importance of these segments in Austco’s future growth, as they represent a significant portion of unfilled contracted revenue.

More about Austco Healthcare Limited

Austco Healthcare Limited is a global leader in clinical communications solutions, focusing on providing advanced communication systems for healthcare facilities. The company is involved in the development and integration of software and hardware solutions aimed at enhancing patient care and operational efficiency in the healthcare sector.

YTD Price Performance: 10.71%

Average Trading Volume: 245,083

Technical Sentiment Consensus Rating: Sell

Current Market Cap: A$112.9M

Find detailed analytics on AHC stock on TipRanks’ Stock Analysis page.